Northwest & Ethical Investments L.P. Moderna, Inc. Transaction History
Northwest & Ethical Investments L.P.
- $3.79 Trillion
- Q3 2024
A detailed history of Northwest & Ethical Investments L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 14,068 shares of MRNA stock, worth $472,825. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,068
Previous 14,068
-0.0%
Holding current value
$472,825
Previous $940 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
911Shares Held
235MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.35 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.31 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$859 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$566 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$243 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...